Skip to main content
. 2025 Aug 26;30:806. doi: 10.1186/s40001-025-03001-8

Table 2.

Basic Characteristics of Participants by Monocyte-Albumin-Ratio Quartiles

Characteristic Na Monocyte-Albumin-Ratiod P Valuec
Overall, N = 15,679 (100%)b Q1, N = 4108 (25%)b Q2, N = 4088 (26%)b Q3, N = 3603 (24%)b Q4, N = 3880 (24%)b
Age (years) 15,679 47.0 (34.0, 60.0) 45.0 (33.0, 57.0) 46.0 (33.0, 59.0) 48.0 (33.0, 61.0) 50.0 (35.0, 65.0)  < 0.001
Gender 15,679  < 0.001
 Male 7507 (48%) 1742 (41%) 1849 (46%) 1809 (51%) 2107 (54%)
 Female 8172 (52%) 2366 (59%) 2239 (54%) 1794 (49%) 1773 (46%)
Race/Ethnicity 15,679  < 0.001
 Non-Hispanic white 6636 (68%) 1401 (62%) 1681 (67%) 1624 (70%) 1930 (72%)
 Non-Hispanic black 3146 (10%) 905 (12%) 828 (11%) 672 (9.4%) 741 (9.5%)
 Mexican American 2501 (8.7%) 697 (9.8%) 706 (9.0%) 577 (8.5%) 521 (7.4%)
 Other race—including multi-racial 1805 (7.7%) 678 (11%) 469 (7.5%) 331 (6.3%) 327 (6.3%)
Other Hispanic 1591 (5.8%) 427 (5.8%) 404 (5.7%) 399 (6.2%) 361 (5.3%)
Education level 15,679  < 0.001
 Under highschool 3906 (16%) 960 (15%) 984 (15%) 947 (17%) 1015 (18%)
 Highschool 3572 (23%) 862 (21%) 869 (21%) 814 (23%) 1027 (29%)
 Above highschool 8201 (61%) 2286 (65%) 2235 (64%) 1842 (60%) 1838 (53%)
Poverty-income ratio (PIR) 15,679 2.74 (1.60, 4.86) 3.00 (1.79, 4.97) 2.79 (1.64, 5.00) 2.78 (1.61, 5.00) 2.41 (1.42, 4.41)  < 0.001
Body Mass Index (kg/m2) 15,679 28 (24, 32) 26 (23, 30) 28 (24, 32) 28 (25, 33) 29 (25, 35)  < 0.001
Systolic Blood Pressure (mmHg) 15,679 120 (111, 128) 119 (109, 125) 120 (110, 127) 120 (112, 128) 120 (113, 131)  < 0.001
Diastolic Blood Pressure (mmHg) 15,679 69 (64, 75) 69 (65, 75) 69 (65, 76) 69 (64, 75) 69 (63, 76) 0.5
Alcohol Consumption 15,679 0.04
 No 15,319 (98%) 4,021 (98%) 4,010 (98%) 3,506 (97%) 3,782 (98%)
 Yes 360 (2.1%) 87 (1.9%) 78 (1.5%) 97 (2.5%) 98 (2.4%)
Smoking status 15,679  < 0.001
 Smoking 3058 (19%) 556 (12%) 664 (16%) 769 (22%) 1069 (28%)
 Never smoking 8776 (55%) 2650 (64%) 2441 (59%) 1933 (53%) 1752 (45%)
 Quit smoking 3845 (25%) 902 (24%) 983 (25%) 901 (26%) 1059 (28%)
Diabetes 15,679  < 0.001
 Diabetes 2462 (11%) 487 (8.4%) 573 (8.9%) 603 (11%) 799 (17%)
 Prediabetes 3843 (21%) 842 (16%) 971 (19%) 910 (22%) 1120 (26%)
 Nondiabetes 9374 (68%) 2779 (75%) 2544 (72%) 2090 (67%) 1961 (57%)
Cancer 15,679 0.034
 No 14,222 (90%) 3794 (91%) 3748 (91%) 3256 (90%) 3424 (89%)
 Yes 1457 (9.7%) 314 (9.2%) 340 (8.8%) 347 (9.7%) 456 (11%)
Stroke 15,679  < 0.001
 No 15,082 (97%) 4000 (98%) 3963 (98%) 3470 (97%) 3649 (95%)
 Yes 597 (2.9%) 108 (1.9%) 125 (2.3%) 133 (2.9%) 231 (4.6%)
HDL cholesterol (mmol/L) 15,679 1.34 (1.11, 1.63) 1.42 (1.19, 1.73) 1.37 (1.14, 1.68) 1.32 (1.09, 1.58) 1.27 (1.06, 1.55)  < 0.001
LDL cholesterol (mmol/L) 15,679 2.87 (2.30, 3.52) 2.90 (2.35, 3.54) 2.92 (2.35, 3.54) 2.90 (2.33, 3.54) 2.79 (2.25, 3.41)  < 0.001
Total cholesterol (mmol/L) 15,679 4.89 (4.24, 5.61) 4.94 (4.32, 5.64) 4.94 (4.29, 5.61) 4.91 (4.22, 5.61) 4.78 (4.14, 5.51)  < 0.001
Total triglycerides (mmol/L) 15,679 1.14 (0.78, 1.66) 1.03 (0.71, 1.51) 1.07 (0.76, 1.57) 1.20 (0.84, 1.74) 1.24 (0.86, 1.82)  < 0.001

aN not Missing (unweighted)

bMedian (IQR) for continuous; n (weighted %) for categorical

cDesign-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment

dMonocyte-Albumin-Ratio is grouped based on quartiles: Q1: < 0.095; Q2: 0.095–0.122; Q3: 0.122–0.152; Q4: > 0.152